Elevated hepatic enzymes potentially associated with sitagliptin.
Gross
Benjamin N
BN
Cross
L Brian
LB
Foard
Joni
J
Wood
Yelena
Y
D000410:Alanine Transaminase / Q000187:drug effects / Q000378:metabolism; D001219:Aspartate Aminotransferases / Q000187:drug effects / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D005234:Fatty Liver / Q000150:complications; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000009:adverse effects* / Q000627:therapeutic use; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use
D054873:Dipeptidyl-Peptidase IV Inhibitors; D011719:Pyrazines; D014230:Triazoles; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000068900:Sitagliptin Phosphate